Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Imv Inc (NQ: IMV )

3.340 USD UNCHANGED
Streaming Delayed Price Updated: 4:43 PM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.340
Bid (Size) 3.300 (3)
Ask (Size) 3.630 (1)
Prev. Close 3.340
Today's Range 3.340 - 3.340
52wk Range 1.350 - 6.820
Shares Outstanding 43,197,120
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
IMV to Participate in Two Upcoming Investor Events
IMV to participate at two upcoming investor events 
From Business Wire News Releases
BTV Shines a Light on Companies to Invest In
From Newsfile Corp News Releases

Performance

YTD
+4.70%
+4.70%
1 Month
-5.65%
-5.65%
3 Month
-6.96%
-6.96%
6 Month
-22.33%
-22.33%
1 Year
+25.09%
+25.09%

More News

Read More
TMX Group, IMV, C-Suite at The Open
From PR Newswire
IMV Reports Update on COVID-19 Vaccine Program
From Business Wire News Releases
Durable Clinical Benefits Induced by IMV’s T Cell Therapy in Combination With Merck’s Keytruda in Subjects With PD-L1 Positive r/r DLBCL Presented at ASH Annual Meeting
From Business Wire News Releases
Are These The Best Penny Stocks To Buy Now? 5 Biotech Stocks To Know
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
IMV’s Survivin-Targeted T Cell Therapy Shows Durable Clinical Benefits in Phase 2 Study in Patients with Hard-to-Treat Advanced Recurrent Ovarian Cancer
From Business Wire News Releases
12 Health Care Stocks Moving In Monday's After-Market Session
Tags CFMS ALT General
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tags ADXN IMV NEOS
From Benzinga
IMV to Host a Key Opinion Leader Webcast on the Ovarian Cancer Treatment Landscape and Data Highlights from the Phase 2 Trial of a Novel T-Cell Therapy
From Business Wire News Releases
12 Healthcare Stocks Moving In Thursday's Pre-Market Session
Tags OBLN ITRM OMER
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]